Adjuvant Therapy for Urothelial and Renal Cell Carcinoma

Hiten D. Patel, Max Kates, Mohamad E Allaf

Research output: Contribution to journalComment/debatepeer-review

Abstract

Adjuvant therapy for urothelial and renal cell carcinoma has progressed steadily over the past 30 yr, with immune checkpoint blockade poised to shift the landscape.

Original languageEnglish (US)
JournalEuropean Urology Focus
DOIs
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Adjuvant Therapy for Urothelial and Renal Cell Carcinoma'. Together they form a unique fingerprint.

Cite this